KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Retained Earnings (2016 - 2026)

Bristol Myers Squibb has reported Retained Earnings over the past 18 years, most recently at -$1.4 billion for Q1 2026.

  • Quarterly Retained Earnings fell 108.51% to -$1.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.4 billion through Mar 2026, down 108.51% year-over-year, with the annual reading at -$1.5 billion for FY2025, 23.1% down from the prior year.
  • Retained Earnings was -$1.4 billion for Q1 2026 at Bristol Myers Squibb, up from -$1.5 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $25.5 billion in Q4 2022 and troughed at -$1.6 billion in Q2 2025.
  • The 5-year median for Retained Earnings is -$1.2 billion (2024), against an average of $7.4 billion.
  • Year-over-year, Retained Earnings surged 1351.71% in 2024 and then crashed 108.51% in 2026.
  • A 5-year view of Retained Earnings shows it stood at $25.5 billion in 2022, then crashed by 106.06% to -$1.5 billion in 2023, then increased by 19.92% to -$1.2 billion in 2024, then dropped by 23.1% to -$1.5 billion in 2025, then rose by 10.1% to -$1.4 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Retained Earnings are -$1.4 billion (Q1 2026), -$1.5 billion (Q4 2025), and $17.1 billion (Q3 2025).